Class II
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Subpotent drug
- Recall number
- D-0575-2025
- Report date
- August 20, 2025
- Classification
- Class II
- Status in dataset
- Ongoing
- Recalling firm
- Pfizer
- Generic names
- LEVOTHYROXINE SODIUM
- Brand names
- LEVOXYL
- Product NDCs
- 60793-850, 60793-851, 60793-852, 60793-853, 60793-854, 60793-855, 60793-856, 60793-857, 60793-858, 60793-859, 60793-860
Code and lot information
Lot #: 24C11, Exp 2/28/2026.
Distribution
Within U.S
Do not stop or change a prescribed medication based only on this page.Contact your pharmacist or prescriber and compare the exact product, manufacturer, NDC, and lot information.
Source and limitations
This page reflects a public openFDA Drug Enforcement record. The dataset was last checked on September 23, 2026. openFDA states that enforcement data should not be used alone to issue public alerts or track the full lifecycle of a recall.
Review the official FDA Drug Recalls page and the underlying openFDA query.